Federal Register Notice: FDA is making available a guidance for industry entitled Photosafety Testing. This guidance provides recommendations on when to test for photo-irritation and assess the potential of drug products to enhance ultraviolet-associated skin carcinogenesis. To download the guidance, click here. To view this notice, click here.
